Overview

A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
0
Participant gender:
All
Summary
A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Treatments:
Nebivolol
Criteria
Inclusion Criteria:

- An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and
less then or equal to 109 mmHg at baseline

Exclusion Criteria:

- Recent myocardial infarction or stroke

- Secondary hypertension

- Contraindications to beta-blocker therapy or discontinuation of prior antihypertensive
agents

- Pregnancy, nursing or women of childbearing age not using appropriate contraception